MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
Creyos Health
Creyos Health is a scientifically validated, clinician-trusted, and patient-friendly platform that combines proprietary online tasks with digitized behavioral health questionnaires. Healthcare providers receive a complete, research-backed solution for detecting cognitive impairment and behavioral health conditions that is flexible, engaging, accurate, and reimbursable. The platform is backed by over 30 years of scientific research and has been used in more than 400 peer-reviewed studies. Over 10,000 healthcare providers trust Creyos in their practices to evaluate patient cognition and behavioral health. Creyos offers a suite of 12 online cognitive tasks, each taking only 2-3 minutes to complete, designed to detect even mild cognitive impairment. These tasks assess key domains such as short-term memory, reasoning, concentration, and verbal ability. The platform also includes digitized behavioral health screeners that automatically tabulate results, providing quick insights.
Learn more
SWE-2
SWE-2 is Cognition’s advanced coding model designed to improve software engineering performance while reducing the cost of agentic coding workflows. The model is post-trained from Kimi K3 and uses reinforcement learning to optimize multiple reasoning-effort levels within a single training run. SWE-2 is designed to explore codebases more selectively, begin implementation sooner, and complete tasks with fewer redundant reads and reasoning steps than earlier Cognition models. Its capabilities include code generation, debugging, test creation, verification, repository analysis, and complex terminal-based software engineering tasks. The model also emphasizes stronger engineering judgment, end-to-end test coverage, instruction following, and evidence-based verification of user assumptions. SWE-2 is available through Devin Desktop and Devin CLI, with broader rollout planned across Devin Web and Fusion.
Learn more
BrainFx
Specifically designed to detect what other cognitive tests can miss, BrainFx’s interactive digital cognitive assessments help health professionals better understand a person’s neurofunction, quickly illuminate mild to moderate dysfunction and deliver unique insights for creating more, targeted treatment plans through real-world contextual, function-based activities. BrainFx assessments use the innovative Neurofunctional approach to assessing cognitive function. This means that you assess more than just cognition because, in the real-world, other factors like one’s psychosocial and physical health, or environmental and task-related characteristics can positively or negatively influence cognitive function. By taking the Neurofunctional approach in the design of the assessments, BrainFx’s activities can be more real-world and function-based, more challenging, and ultimately more sensitive. This enables BrainFx assessments to detect what other tests can often miss.
Learn more